Thailand’s Herbal Remedy Beating Mild COVID-19—90.02% Success Rate in Study with 11,800 Prison Inmates

Thailand was hit hard with the Delta variant surge, and vaccination experienced a slow start as the manufacturer granted the license to produce the AstraZeneca/Oxford vaccine had no real experience in vaccine production. Now reports indicate that a cheap, herbal medicine might just be working to treat SARS-Cov-2, the virus behind COVID-19. Just a couple months ago, Thailand's national cabinet actually approved green chiretta for use in people with asymptomatic or mild COVID-19 infections following a successful study in the prison system here. Most of the nation’s jails now use the herbal remedy with a remarkable track record to the study—90.02% that took the drug got better. These are better results than Molnupiravir, ivermectin, favipiravir, and remdesivir (the latter in a hospital setting). While the drug isn’t a silver bullet nor cure, it may be just what the doctor ordered to treat the 90% of COVID-19 cases that are simply asymptomatic or mild in nature. While the data must still be substantiated, this could be game-changing, bombshell information.

An Answer to Crisis?

Often packed, overcrowded jails were infection-rich environments for the SARS-CoV-2 pathogen. With...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee